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coronary events @ 30 days included death 1.5%, Q-wave Ml 1.1%, CABG
3.6%, and repeat PTCA 3.6% (ANY event in 6.7% pts).
/n Corrc/usion: the new GRII’” coronary stent provides improved deliv-
erability to complex lesion sites with excellent resolution of AC syndromes.
However, additional therapies may be required (e.g. stent coatings, ReoPro)
in AC pts to reduce SAT and diminish 30-day major adverse clinical events.
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-j EchocardiographycanPredicttheDevelopment
of SevereMitralReauraitetionAfterPercutaneous
MitralValvuloplae~-W~hthe Inoue(Single
Balloon)Technique
L.R. Padial, V.M. Abeacel, P.R.Moreno, A.E. Weyman, R.A. Lavine,
LF. Palacioa. Massachusetts General Hospital, Haward Medicel School,
Boston, MA, USA
We have previously described an echocardiographic score (MR-Echo Smre)
based on mitral valve morphology (unevenly thickened leaflets, diffuse in-
volvement of the commissures and subvalvular apparatus) which can predict
the development of aevere mitral regurgitation (MR) after percutaneous mi-
tral valvuloplasty (PMV) using the double balloon technique. Whether the
same score can be uaed to predict severe MR in patients undergoing PMV
with the Inoue technique is unknown. Therefore, we prospectively studied
60 consecutive patients (11 men; 57 + 14 yrs) who underwent PMV by the
Inoue technique. Eleven patients developed severe MR (angio ? 3+) after
the procedure. No significant differences were obsenfed between them and
those who did not develop savere MR in age (60 + 10 vs. 57 + 14 yrs; p =
0.40), Wilkins’ score (6.7 + 1.5vs. 7.6 +2.0; p =0.06) or dilating balloon size
(26.7 + 1.1 vs. 27.1 + 1.5 cm; p= 0.07), whereas a significant difference was
noted in MR-Echo Score (10.5 + 1.4 vs. 6.2 + 1.1; p = 0.0001). Nine (62%)
patients with severe MR and 6 (9%) without MR had an MR-Echo Score
z 10 (p < 0.00001). Thus, the MR-Echo Score has a sensitivity of 6.20/.,a
specificity of 91%, a positive predictive valUe of 60Y0,a negative predictive
valUOOf 97% and an accuracy Of 90?’. fOr predicting the development Of
severe MR after PMV with the Inoue technique, similar to those with double
balloons. In conclusion, MR-Echo Score can also predict the development of
severe MR in patients undergoing PMV with the Inoue technique.
m103778 Transluminalendovasculargraftplacementforthetreatmentof thoracicaorticaneuryems
K. Inoue, T. Iwase, M. Sate, Y.Yoshida, S. Tamaki, A. Yamazato,
H. Hosokawal, T. Suzuki 1. TakedaHoapital, Kyoto, Japan, 1SVations/
ToyohashiEast Hospital, Aichi, Japan
Redescribe ourinitialclinicel experience in repainngthoracic aorticaneurysms
using a new device. The procedure was performed in 13 patients with tho-
racic aortic aneurysm. The endovascular grafting system was designed and
developed by Inoue et al.The new graft was constructed from a Dacron
cylinder and the surface of the graft was supportad by multiple rings of
extra-flexible wire. After the folded graft was delivered to the predetermined
target point through the eheath, the graft was deployed, and then pressed
against the aortic wall by balloon inflation. Straight graft insertion was at-
tempted in 11 patients and branched graft insertion in 2 patients. There were
trua aneurysm in 2 patients, aortic dissection in 9, true aneurysm and aortic
dissection in 1, pseudoaneurysm in 1. The implantation site was the distal
arch in 6 patients, and the descending thoracic aorta in 7. The grafts were
successfully placed in 12 patients and technical failure occurred in 1. The
procedure was terminated because the branched graft did not pass through
the 22 French sheath. Thrombeais of the aneurysm surrounding the graft
was complete in 7 patients within one week. The remaining 5 patients had
either proximal communication or diatal communication with the aneurysm.
Thedegreeof leakage was mild in 3 patients, moderate in 2. We encountered
microembolization in 1 patient. For 1 patients with moderate leakage, second
endovascular placement of the branched graft waa successfully performed.
Three patients with mild leakage have continued to be obeewed closely.
There have been no deaths or instances of paraplegia. There have been
no graft migration, extrevasation, resultant aneurysm, evidence of aneurysm
enlargement, graft distraction or significant graft stenosis during a mean
follow-up period of 9 months. Initial clinical results demonstrated the efficacy
and safely of endovascular graft placamant using the new graft.
11037-79I BalioonAngioplastYofNativeCoarctationin
AdolescentsendAdults,2-10 YearFollowUp
Results
ME. Fawzy,V, Sivanandam, A. Rifai, B. Dunn, W. von Sinner, A.A. Patel,
J. Lingamanaicker, K.A. Niazi, King Faisa/ Specialist Hospita/& Research
Centre, Riyadh, Saudi Arabia
The long term result of balloon angioplasty (BA) in adult aortic coarctation
(AC) has not been well characterized. 41 consecutive adult patients (pta) with
nativeAC underwent BAbetween July 1966and July 1996.Theirages ranged
from 15-55 (mean 22 + 7) years (yrs). Dissection of the aorta developed in
one patient. Datawere collected on the remaining 40 pts. Clinical examination
and serial study by cardiac catheterization and magnetic resonance imaging
(MRI) were carried out in 36 pts, 2-10 yrs (mean 6 yrs) after dilatation.
Resu/ts:Peaksystolic gradient (PSG) before dilatation was36-100 (mean
64 + 24) mmHg and decreased to 12 + 8 mmHg p <0.001 immediately
after dilatation. Restenosis (defined as gradient >30 mmHg across AC site)
occurred in 2 pts and 1 pt had incomplete dilatation. The 3 pts underwent
rediiatation and remain improved 5 years later. There was no significant
change in PSG across AC in the remaining 26 pts at follow up, it ranged from
0-15 (mean 7.5 + 6) mmHg, Three pts developed small aneurysms which
did not increase in size 5 years later, Blood pressure was controlled without
medication in 27 pts and required medication in the remaining pts.
Conclusion: (1) It is concluded that the long term result of balloon angio-
plasty of nativa coarctation in adolescents and adults is satisfactory. (2) The
blood pressure normalized in 75% of patients without medication,
[-l An EchOcardiOgraphicStudyof the MitralVakein
PatientsWhoFailto Increasethe MitralValve
AreaAfterPercutaneousMitralValvuloplasty:
Roleof CommissuresandSubvalvularDisease
L,R. Padiai, V.M. Abascal, P.R.Moreno, A.E. Weyman, R.A, Levine,
LF. Palacios, Massachusetts General Hospital, Harvard Medical School,
Boston, MA, USA
Little is known about why some patients fail to increase mitral valve area
(MVA) after percutaneous mitral valvuloplasty (PMV). To study whether this
can be due to some morphologic features of the mitral valve, 12 patients (all
women; 59 + 11yrs) whose MVA did not increasa after PMV (change s 0.1
cm2) were compared with 100 consecutive patients (66 women; 56+ 14 yre;
31 double balloon PMV) whose MVA significantly increased. The mitral valve
was studied using a previously deecrfbed echocardiographic score aimed to.
predict the development of severe mitral regurgitation after PMV (MR-Echo
Score). This score takes into account unevenly thickened leaflets and diffuse
involvement of the commissures and subvalvular apparatus. No significant
differences were noted in age, MVA pre-PMV (1.0 + 0.1 vs. 0.9 + 0.2 cmz),
degree of MR pre-PMV, Wilkins’ score (7.9 + 2.5 vs. 7.7 + 1.9) or balloon
size (3.5 + 0.4 vs. 3.6 + 0.4 cm2/m2) between the two groups. Significant
differences were observed in the MR-Echo Score (10.3 & 2.3 vs. 6.1 + 1,1;
p = 0.0001) and its individual components for commissures (2.7 & 0.8 VS.
1.9 + 0.4; p = 0.0006) and subvalvular disease (3.0+ 0.9 vs. 2.1 + 0.6; p =
0,0002), without significant differences in the degree of leaflet diseaae.
Cone/uaion:Patients who fail to increase MVA after PMV have more se-
vere disease of the commissures and the subvalvular apparatus. This might
potentially limit commissural splitting and relief of subvalvular restriction.
m103781 Predictorsof MitralRestenosisFollowingMitralBalloonValvuloplastyin360Patients
M.E. Fawzy,V. Sivanandam, S. Wahi, L. Mimish, B. Dunn, K.A. Niezi,
O. Ismail, B.A. Khan, Z. Al Halees. King Faisa/ Specialist Hospita/ &
Research Centre, Riyadh, Saudi Arabia
Background: Mitral ballcrm valvuloplasty (MBV) is an effactive method in
the treatment of patients .(pts) with severa mitral stenosis (MS). Although
factors determining immediate result of MBV have been described, there
is little information regarding the predictors of restanosis following MBV.
Methods: From December 1969 to July 1996, 360 pts underwent successful
MBV for severe MS. 267 had completed clinical and Echo Doppler study
with a mean follow up of 42 + 15 (12 to 68) months. 49 pts developed
restenosis (16.4%), (defined as 50% loss of initial gain in Doppler mitral
valve area (MVA) or follow up MVA c 1.2 cm2). 3Y0 of pts of mitral Echo
score (MES) < 6 developed restenosis, and 6Y0 in those with MES = 6
and 56% with those >8 MES. Multivariate Cox Regression analysis of 10
different baseline characteristics: age, sex, atrial fibrillation, NYHA class,
MES, immediate Doppler MVA, mitral gradient, left atrial eize, cardiac index,
pulmonary arleriolar resistance. Resu/ts: The analysis identified that the
suboptimal result (immediate MVA <1.5 cm2), and high MES were the only
independent predictors of restenosis (P< 0.001).
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Conclusion: Unfavorable mitral valve anatomy represented by high mitral
Echo score ia the main cause of mitral restenosia following MBV.
C3103782 HighRateof RestenoeisFollowingCoronaryAngioplaatyin PatientawithChronicRenal
Failure
F. Gradaua, F.C. Schaebel, K. Ivens, P.Heering, T.W.Jax, M. Leschke,
B.E. Strauer. Clinic of Certlibhgx Heinrich-Heirre Universitift, Dikeeldoti
Germany
Retrospective observational studies suggest a high rate of restenoaiafollow-
ing oaronary angioplasty in patients with end-stage renal disease (ESRD)
undergoing chranic hemcdialyais. A study which investigates the rate of
restenosis in comparison to controls in reapecf to procedural variables and
csrdiovaacular risk factors has not been performed.
In 20 patients on maintenance hemcdialysis and in 20 age- and sex-
matched patients without renal disease corona~ stenosis waa assessed
by computer aseiated quantitative coronary angiography before and after
elective and primarily successful PTCA and at a follow-up caronary angiog-
raptry after 6 months. Plasma concentrations of lipids and fibrinogen were
measured before PTCA.
The rate of restenosis (stenosia =- 50% Iuminal diameter) was 60% in
patients with ESRDand35% in carrtrols.Procedural variables Iikethedegree
of atenosis before (69 =t 9 vs. 65 * 6%) and after PTCA (37 + 6 va. 35 +
11%) as well as the complexity of stenosis dilated did not differ between
both groups. In patients with ESRD concentrations of fibrinogen (463+ 101
VS. wo * 84 r-ngktl,p < 0.001) and triglycerides (269 + 163 vS. 207 &
176 mg/dl, p e 0.01) were significantly elevated in comparison to controls,
while concentrations of total cholesterol (262 +50 vs. 236 +39 mg/dl) LDL-
cholesterol (191 +50 vs. 172 +38 mgldl) and HDL-cholesterol (36+ 15 vs.
42+ 12 m~dl) were comparable.
In this first controlled atudy a high rate of restenosis could be confirmed
in patiente with ESRD. Given the role of reactive thrombogenesis in theearly
phasefollowingcoronaryangioplastyprocoagulantfactorslikeelevationsof
fibrinogenand triglyceridesas a pasaiblemarkerof impairedendogenous
fibrinolyaiamayinfluencetheprocessof restenosisinpatientswithend-stage
ranaldisease.
m Novel Pharmacologic Therapies for
Reatenosis After PTCA
Wednesday,March 19, 1997, 9:00 a.m.–n :00 a.m.
AnaheimConventionCenter,Hall E
PresentationHour:9:00 a.m.-l O:OOa.m.
I1038-7O]Atheroscleroeisprogre~ionin~u~ia~tsw,t~an~
withoutPost-AngioplaetyReatenosisinQUIET
L. Cashin-Hemphill, R.E. Dinsmore, R.C. Chan, S.N. Williams,
G. Holmvang, H.E. Haber, R.S. Lees for the QUIET Investigators. Boston
Hearf Foundation, Cambridge, MA, USA
The Quinapril Ischemic Event Trial (QUIET) randomized 1750 subjects within
72 hrs of successful PTCA to Quinaprfl 20 mg (Q) or placebo (P) for three
years. The clinical endpaint was time to first cardiac ischemic event in the
full cohort.Followupangiogramswereperfomredin 453 subjects to assess
atherosclerosis progression by QCAin non-intervenedarteries.Resteno-
sis (narrowingwhichwaa ? baselinepre-intervention)wasalsoassessed
visuallyat threeyears.Subjectswho underwent‘ire-do”PTCAduringthe
studywere includedin orderto determinethe total restenosisrate.Of the
453 angicgraphicsubstudysubjecta,164 (76 Q, 86 P, p > 0.05)experi-
enced reatenoaiafor a total rate of 38%.Sixty-oneasymptomaticreetenoses
(13%)were found only at elective three year follow-up angiogram. Early
symptomatic restenasia occurred in 103 subjects (23%). Progression, de-
fined as a 0.40 mm diminution in minimum lumen diameter in a diseased,
non-intervened artery, occurred as followa (p >0.05 for all oamparisana):
AnglogrsphlcProgressors
Placebo(n=229) Quinapril(n=224) Overall(n=453)
Reetanoeie(n= 164) 42J86(50%) 35/ 78(45%) 78/164(48%)
No-Raatenosia(n= 289) 64/143(45%) 67/146(46%) 131/26(45”/6)
We concludethat:1)Sinceatherosclerosisprogressionwaasimilarinthe
restenosiaandno-restenosiagroups, the two procesaeeappear to be patho-
phyaiologically independent. 2) As there was nodifference in reetenosierates
between treatad and placebo groups, the QUIET data suggeets that even
ACE-inhibitors with high tissue affinity do not significantly lessen reatenosis.
~1038-71 I LocalAdministrationof L-7f)3,8fNwitha
CompositePolymerStentReducesPlatelet
DepositioninCanineCoronaryArteries
R.M. Santos, J.-F. Tanguay,K.R. Kruse, J.J. Crowley, J,P. Zidar, Y. Merhi,
E. Garcia-Cantu, R. Bonan, G. C6te, R.S. Stack. Duke University Medicd
Center Durham, NC, USA, Montreal Heart Institute, Montrdal, Quebec,
Canada
Systemic inhibition of platelet glycoprotein llb/llla is effective in reducing 30
day and 6month clinical events following high riakangioplasty, We compared
the effect of L-703,601, a nonpeptide analog of tirofiban, administered Ibcally
with a drug eluting stent to that of standard metal stents on platelet deposition
in canine caronary arteries, Ten mongrel dogs were given 325 mg of aspirin
one day prior to stent implantation. The left anterior descending and left
circumflex arleries were randomly assigned a standard 6 mm slolted metal
tube stent or an 6 mm composite metal/palymer stent incorporated with
L-703,801 (40% by weight). On-line quantitative angiography was uae to
size atenta. Balloon to artery ratios of 1.2-1.3:1 were achieved with infation
pressurea of 10-14 ATM. Platelet deposition determined with ‘tllrr-oxime
waa measured 2 houra after stent implantation. Platelet deposition on drug
loaded stents was significantly less than metal controls: 3.43 (1.91, 3.75) vs.
7.87 (2.53, 11.3) platelets x 107/cm2, p = 0.0186. To determine the effect
of non-dreg loaded polymer, similar studies were performed on 14 animals.
Composite stenta without drug had slightly greater platelet deposition than
metal controls but the difference was not significant: 8.71 (1.97, 12.0) vs.
4.46 (2.43, 17.8) platelete x 107/cm2,p =0.4326. There was no difference in
the proximal reference vessel diameter, the stent minimal lumen diameter or
the stent to artery ratio. Conclusion: Local delivery of L-703,601 is effective
in reducing 2 hour platelet deposition in the canine model of coronary stent
implantation. This study is the first to ahow significantly reduced platelet
deposition by a drug eluting stent compared to standard metal stents.
m103872 Effactof Intracoronary‘Wkridium(1%) on LateQuantitativeAngiographicOutcomesAfterPTCA
J.A. Condado, J.J. Popma, A.J. Lanksy, O. Gurdiel, R. Espinoza, J.G. Brito,
A. Brahimi, B. Burger, L. Hall, M.B. Lwn. Centro Medico De Caracas,
Caracas, Venezuele, Washington Hospital Centec Washington, DC, USA
To evaluate the effect of gamma radiation on the late angiographic outcome
after PTCA, we reviewed the aerial angiograms of 21 patienta (22 lesions)
who received 16-20 Gy 1wlr deliverad via a 3 cm radioactive wire. Quantita-
tive angiography (CMS-GFT) was performed ueing contrast-filled catheters
before and afterPTCA,1-4 montha(N= 12),and>4 months(N= 20) later.
Lesionewerelocatedinthe LAD(50%),RCA(32%),andLCX(18°r&)arteriee.
Lesionlength was9.21 +3.77 mm. After PTCA, 2 patients had small pseudo-
aneurysms. Early (l-4 month) angiography showed 2 total occlusions and 2
(9%) new pseudoaneurysms (one c 2 mm). Serial quantitative angiographic
findings included: MLD = minima/ diameter
Pre Post 1 Month 6 Month
Normal.mm 2.90+0.57 3,01 *6O 2.95+ 0.52 2.90 +0.S0
MLO,Mm 0.9S+0.52 1.94* 0.45 1.61+ 0.s9 1.75* 0.73
0/0Stenosis 66& 16 35& 13 46*2S 41&24
Binary reatenosia(Z 50% follow-up diameter stenosis) occurred in 27%of
lesions, including the 2 patients with early total accluaion. Late Ioas waa 0.19
* 0.78 mm; the loss index (late losa/acute gain) was 0.19. Ten (45%) Iesione
had an increase in lumen diameter during the follow-up period. We conclude
that 1wlrgamma radiation: 1) can be safely performed after PTCA without
an increase in procedural complications, 2) ie associated with infrequent (c
10%) development of late angiographic complications, and 3) appears to
reduce the magnitude of lumen loss after PTCA (late loss= 0.19; loss Index
= 0.19) compared with conventional PTCA.
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H.Yokoi.H.
Effectivanassof Probucolin Preventing
RestenosisafterPercutaneousTransluminal
CoronaryAngioplastyin SmallSizedCoronary
Arteries:A SubgroupAnalyeiaof the Probucol
AngioplastyReetenosisTrial(PART)
)aida, H. Yamaauchi, Y. Kuwabara 1for the PART GrauD.
Juntendo Universi&, Tokyo,japan, 1Chlba Universi~ Chiba, Japan’
To investigate the effectiveness of Probucol in preventing reetenosie after
PTCA in emall aized vessels, we analysed the angiographic reeults of the
PART study. One hundred and one patienta were randomly aasigned to
Probuod or control group. In Pmbuool group, 1000 mg of Probucol was
administered daily for4weeks priorto PTCAand continued until angicgraphic
